» Articles » PMID: 35163601

EphrinB2-EphB4 Signaling in Neurooncological Disease

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Feb 15
PMID 35163601
Authors
Affiliations
Soon will be listed here.
Abstract

EphrinB2-EphB4 signaling is critical during embryogenesis for cardiovascular formation and neuronal guidance. Intriguingly, critical expression patterns have been discovered in cancer pathologies over the last two decades. Multiple connections to tumor migration, growth, angiogenesis, apoptosis, and metastasis have been identified in vitro and in vivo. However, the molecular signaling pathways are manifold and signaling of the EphB4 receptor or the ephrinB2 ligand is cancer type specific. Here we explore the impact of these signaling pathways in neurooncological disease, including glioma, brain metastasis, and spinal bone metastasis. We identify potential downstream pathways that mediate cancer suppression or progression and seek to understand it´s role in antiangiogenic therapy resistance in glioma. Despite the Janus-faced functions of ephrinB2-EphB4 signaling in cancer Eph signaling remains a promising clinical target.

Citing Articles

Exploring the causal relationship between serum EFNB2 levels and epilepsy: a bidirectional Mendelian randomization and co-localization analysis.

Zhang X, Xu Y, Wu Z, Zou X BMC Neurol. 2025; 25(1):84.

PMID: 40045230 PMC: 11881259. DOI: 10.1186/s12883-025-04115-6.


Ciprofol reduces postoperative glioma recurrence by promoting MAPK11-PML phosphorylation: insights from transcriptomic and proteomic analysis.

Li Y, Shi J, Liu C, Ma D, Meng L, Zhang Z J Neurooncol. 2025; .

PMID: 40019711 DOI: 10.1007/s11060-024-04906-w.


Standardization of a Model of Vertebral Metastasis of Breast Cancer in CD1/Nu/Nu Mice.

Reyes Soto G, Miranda-Galvan V, Uribe-Uribe N, Escobar-Valderrama J, Alanis-Mendizabal J, Medina-Velazquez L Cureus. 2025; 17(1):e77291.

PMID: 39931605 PMC: 11809943. DOI: 10.7759/cureus.77291.


Tensile force promotes osteogenic differentiation via ephrinB2-EphB4 signaling pathway in orthodontic tooth movement.

Yu H, Wei X, Jiang H, Qi H, Zhang Y, Hu M BMC Oral Health. 2025; 25(1):118.

PMID: 39844202 PMC: 11755856. DOI: 10.1186/s12903-025-05491-8.


Manipulating the EphB4-ephrinB2 axis to reduce metastasis in HNSCC.

Abdelazeem K, Nguyen D, Corbo S, Darragh L, Matsumoto M, Van Court B Oncogene. 2024; 44(3):130-146.

PMID: 39489818 PMC: 11725500. DOI: 10.1038/s41388-024-03208-9.


References
1.
Dopeso H, Mateo-Lozano S, Mazzolini R, Rodrigues P, Lagares-Tena L, Ceron J . The receptor tyrosine kinase EPHB4 has tumor suppressor activities in intestinal tumorigenesis. Cancer Res. 2009; 69(18):7430-8. DOI: 10.1158/0008-5472.CAN-09-0706. View

2.
Sawamiphak S, Seidel S, Essmann C, Wilkinson G, Pitulescu M, Acker T . Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis. Nature. 2010; 465(7297):487-91. DOI: 10.1038/nature08995. View

3.
Jensen P . Eph receptors and ephrins. Stem Cells. 2000; 18(1):63-4. DOI: 10.1634/stemcells.18-1-63. View

4.
Wang N, Jain R, Batchelor T . New Directions in Anti-Angiogenic Therapy for Glioblastoma. Neurotherapeutics. 2017; 14(2):321-332. PMC: 5398985. DOI: 10.1007/s13311-016-0510-y. View

5.
Tonna S, Takyar F, Vrahnas C, Crimeen-Irwin B, Ho P, Poulton I . EphrinB2 signaling in osteoblasts promotes bone mineralization by preventing apoptosis. FASEB J. 2014; 28(10):4482-96. DOI: 10.1096/fj.14-254300. View